In the LIGHTHOUSE study, Atsena Therapeutics is evaluating ATSN-201 gene therapy for X-linked retinoschisis, leveraging ...

A new study published in the journal of Eye found that the amount of vitamin D and foveal retinal thickness (FRT) in children ...

Atsena Therapeutics, a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent blindness, today announced dosing has been completed in ...

The following is a summary of “Effect of diabetes on short-term outcomes following epiretinal membrane surgery,” published in the December 2024 issue of Ophthalmology by Hecht et al. Researchers ...

1). A foveal color bias has not been reported in previous imaging studies, perhaps because it is more obvious in our flattened maps. However, such a foveal color bias is consistent with the well ...